arrow
F

Fabienne Brilot

nsw health
H指数:57
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of animal models to understand CNS neuroimmunology — guidance from the International Society for Neuroimmunology White Paper Task Force

利用动物模型理解中枢神经系统神经免疫学——国际神经免疫学学会白皮书工作组的指导

2026-10-260
PRE
Comparison of immunity-boosting regimens for COVID-19 upon initiation of immunosuppressive therapy (CIRCUIT): study protocol for a randomised, controlled clinical trial

比较免疫增强方案对免疫抑制治疗开始时COVID-19的影响(CIRCUIT):随机对照临床试验研究方案

2026-04-240
PRE
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function

白细胞中人E3泛素连接酶CBL的体细胞缺陷会损害b细胞,但不会损害T细胞的发育和功能

2026-01-150
OAAI
Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID-19
2025-12-180
OAAI
Live MOG-IgG cell-based assay: Comparison across flow cytometers and diagnostic validation on high-sensitivity full spectrum flow cytometry

活细胞MOG-IgG检测:不同流式细胞仪的比较及在高灵敏度全谱流式细胞术上的诊断验证

2025-09-170
OAAI
Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome

表观遗传学、核糖体和免疫失调在儿童急性发作神经精神综合征中的作用

2025-08-300
OAAI
MOG antibody non-P42 epitope is associated with a higher risk of relapse in paediatric MOGAD
2025-03-011
PRE
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants

二价Omicron BA.1疫苗加强剂增加记忆b细胞宽度并中和针对新兴SARS-CoV-2变体的抗体

2024-12-010
OAAI
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the fi rst four years of the COVID-19 pandemic
2024-12-010
OAAI
The clinical relevance of MOG antibody testing in cerebrospinal fluid
2024-07-285
OAAI
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
2024-05-143
OAAI
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease
2024-01-304
OAAI
International MOGAD criteria
2023-12-010
PRE
Infection and Vaccine Induced Spike Antibody Responses Against SARS-CoV-2 Variants of Concern in COVID-19-Naive Children and Adults

感染和疫苗诱导的针对COVID-19-Naive儿童和成人的SARS-CoV-2变异的尖峰抗体反应

2023-07-050
OAAI
Emergence and antibody evasion of BQ, BA.2.75 and SARS- CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

面对人群水平上成熟的抗体广度,BQ,BA.2.75和传染性非典型肺炎CoV-2的重组亚谱系的出现和抗体逃逸

2023-04-0121
OAAI